Ambuja Cements (AMBUJACEM) — Corporate Action

1 Corporate Action 🔴 High Importance Neutral 📄 PDF

Ambuja Cements announced a scheme of amalgamation with Adani Cementation to be heard by the National Company Law Tribunal on July 3, 2025, and disclosed a board‑approved share buy‑back of up to 60 shares at ₹501 each effective May 14, 2025, with payments scheduled through June 30, 2025.

2 Corporate Action 🔴 High Importance Neutral 📄 PDF

Ambuja Cements received SEBI and NSE observation letters confirming no adverse observations on its proposed scheme of arrangement with Penna Cement Industries. The letters require disclosure of ongoing legal matters, updated financial data within six months, and mandatory demat form for new shares. Shareholders will receive detailed rationale, valuation impact, and asset comparisons before voting. The scheme remains subject to NCLT approval and regulatory compliance.

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this corporate action affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 14 May 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 14 May 2025

SBIN State Bank of India Corporate Action TATAPOWER Tata Power Company Limited Financial Results TATAPOWER Tata Power Company Limited Corporate Action TATAPOWER Tata Power Company Limited Financial Results TATAPOWER Tata Power Company Limited Corporate Action TATAPOWER Tata Power Company Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.